Hyperinsulinemia in Obesity, Inflammation, and Cancer

Article information

Diabetes Metab J. 2021;45(4):622-622

Publication date (electronic) : 2021 July 30

doi : https://doi.org/10.4093/dmj.2021.0131

Anni M.Y. Zhang ¹, Elizabeth A. Wellberg ², Janel L. Kopp ¹, James D. Johnson ¹

¹Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada

²Department of Pathology, University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Harold Hamm Diabetes Center, Oklahoma City, OK, USA

Diabetes Metab J 2021;45:285-311. https://doi.org/10.4093/dmj.2020.0250

In the article cited above, there was a spelling error in the Fig. 1. In the middle of Fig. 1, “obsity” was misspelled. The correct word is “obesity.”

Fig. 1.

Trade-offs with insufficient and excessive circulating insulin levels.

We apologize for any inconvenience that this may have caused.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fig. 1.

Trade-offs with insufficient and excessive circulating insulin levels.